AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2020
Apr 16, 2020
33003_dirs_2020-04-16_0a934a32-139a-43db-8308-7e638d652c87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-04-15
Reporting Person: SMITH IAN F (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.24 | 2030-02-10 | Common Stock (60000) | Direct |
Footnotes
F1: This option was granted on February 10, 2020 and vests in full July 31, 2020, subject to continued service as a consultant.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19